Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats

類似資料

• Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
  著者:: Gunarathne, Lakmie S, 等
  出版事項: (2020)
• Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
  著者:: Rajapaksha, Indu G., 等
  出版事項: (2021)
• Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension.
  著者:: Westaby, D, 等
  出版事項: (1984)
• Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
  著者:: Ørntoft, Nikolaj Worm, 等
  出版事項: (2021)
• Therapeutic potential of targeting the renin angiotensin system in portal hypertension
  著者:: Herath, Chandana B, 等
  出版事項: (2013)